Jonathan McNeill
2023
In 2023, Jonathan McNeill earned a total compensation of $2.2M as Chief Business Officer at Dyne Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $230,880 |
|---|---|
| Option Awards | $522,287 |
| Salary | $430,468 |
| Stock Awards | $1,046,199 |
| Other | $996 |
| Total | $2,230,830 |
McNeill received $1M in stock awards, accounting for 47% of the total pay in 2023.
McNeill also received $230.9K in non-equity incentive plan, $522.3K in option awards, $430.5K in salary and $996 in other compensation.
Rankings
In 2023, Jonathan McNeill's compensation ranked 443rd out of 2,647 executives tracked by ExecPay. In other words, McNeill earned more than 83.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 443 out of 2,647 | 83rd |
Division Manufacturing | 255 out of 1,447 | 82nd |
Major group Chemicals And Allied Products | 176 out of 817 | 79th |
Industry group Drugs | 173 out of 783 | 78th |
Industry Pharmaceutical Preparations | 107 out of 555 | 81st |
Source: SEC filing on April 5, 2024.
McNeill's colleagues
We found two more compensation records of executives who worked with Jonathan McNeill at Dyne Therapeutics in 2023.